CHANGES TO MARTELA’S BUSINESS UNIT ORGANISATION MARTELA

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CHANGES TO MARTELA’S BUSINESS UNIT ORGANISATION

MARTELA CORPORATION       STOCK EXCHANGE RELEASE  29 APRIL 2015 at 8.30 a.m. CHANGES TO MARTELA’S BUSINESS UNIT ORGANISATION Martela has decided to integrate its Business Unit Poland into Business Unit International. Business Unit International previously included Martela’s operations in Russia and exports to countries where Martela does not have a subsidiary. After the changes have been made, Business Unit International will consist of Martela’s sales operations in Poland and Russia as well as exports. The unit will be headed by Veli-Matti Savo, who previously served as Director of Business Unit International. He will also continue to be responsible for the Martela Group’s marketing. Marcin Rutkowski, current Director of Business Unit Poland, will continue in his position and report to Veli-Matti Savo. After the changes, the Group’s Management Team will consist of Heikki Martela (CEO), Ari-Matti Purhonen (VP, Business Unit Finland and Group Product Portfolio), Veli-Matti Savo (VP, Business Unit International and Marketing), Petri Boman (VP, Supply Chain Management and R&D) and Markku Pirskanen (CFO). The organisational change will take effect on 1 May 2015. Martela Corporation Heikki Martela Managing Director More information: Martela Corporation Heikki Martela, Chief Executive Officer, tel. +358 50 502 4711 Markku Pirskanen, Chief Financial Officer, tel. +358 40 517 4606 Distribution Nasdaq Helsinki Main news media www.martela.fi

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading